1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?

BACKGROUND: Vancomycin (VAN) combined with a β-lactam (COMBO) expedites MRSA bacteremia clearance compared with VAN alone. However, the impact of COMBO on persistent MRSA bacteremia (PB) using a contemporary definition of ≥5 days is unknown. There is also no consensus on which β-lactam (BL) should b...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Open Forum Infect Dis
Päätekijät: Dilworth, Thomas J, Casapao, Anthony M, Ibrahim, Omar M, Jacobs, David M, Bowers, Dana R, Beyda, Nicholas D, Mercier, Renee-Claude
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253209/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.903
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia